uniQure NV (QURE)
4.54
+0.14
(+3.18%)
USD |
NASDAQ |
Jun 27, 16:00
4.545
0.00 (0.00%)
After-Hours: 20:00
uniQure Accounts Receivable (Quarterly): 10.72M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.72M |
December 31, 2023 | 4.193M |
September 30, 2023 | 1.644M |
June 30, 2023 | 102.56M |
March 31, 2023 | 104.79M |
December 31, 2022 | 102.38M |
September 30, 2022 | 3.603M |
June 30, 2022 | 3.119M |
March 31, 2022 | 38.64M |
December 31, 2021 | 58.77M |
September 30, 2021 | 3.771M |
June 30, 2021 | 2.705M |
March 31, 2021 | 5.445M |
December 31, 2020 | 6.618M |
September 30, 2020 | 0.223M |
June 30, 2020 | 0.222M |
March 31, 2020 | 0.258M |
December 31, 2019 | 0.947M |
September 30, 2019 | 0.101M |
June 30, 2019 | 0.355M |
March 31, 2019 | 0.461M |
December 31, 2018 | 0.233M |
Date | Value |
---|---|
September 30, 2018 | 0.552M |
June 30, 2018 | 1.037M |
March 31, 2018 | 1.057M |
December 31, 2017 | 1.586M |
September 30, 2017 | 1.945M |
June 30, 2017 | 5.817M |
March 31, 2017 | 1.75M |
December 31, 2016 | 9.18M |
September 30, 2016 | 10.92M |
June 30, 2016 | 7.449M |
March 31, 2016 | 5.791M |
December 31, 2015 | 4.129M |
September 30, 2015 | 5.786M |
June 30, 2015 | 3.628M |
March 31, 2015 | 2.648M |
December 31, 2014 | 2.95M |
September 30, 2014 | 1.444M |
June 30, 2014 | 1.982M |
March 31, 2014 | 0.3205M |
December 31, 2013 | 1.968M |
September 30, 2013 | 3.747M |
December 31, 2012 | 0.0344M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.101M
Minimum
Sep 2019
104.79M
Maximum
Mar 2023
22.55M
Average
3.687M
Median
Accounts Receivable (Quarterly) Benchmarks
ProQR Therapeutics NV | -- |
Merus NV | 58.73M |
argenx SE | -- |
Pharming Group | 38.70M |
Pharvaris NV | -- |